This retrospective study describes the long-term results of core decompression and placement of a non-vascularised bone graft in the management of avascular necrosis of the femoral head. We treated 80 hips in 65 patients, 18 by a cortical tibial autograft and 62 by a fibular allograft. The mean age of the patients was 36 years ( SD 13.2). A total of 78 hips were available for evaluation of which pre-operatively six were Ficat-Arlet stage 0, three stage I, 31 stage IIA, 16 stage IIB, 13 stage III and nine stage IV.
A total of 34 hips (44%) were revised at a mean of four years ( SD 3.8). Survivorship analysis using a clinical end-point showed a survival rate of 59% five years after surgery. We found a significant difference (p = 0.002) in survivorship, when using a clinical and radiological end-point, between the two grafts, in favour of the tibial autograft. We considered this difference to be the result of the better quality and increased volume of tibial bone compared with that from the trochanteric region used with the fibular allograft. This is a relatively simple, extra-articular and reproducible procedure. In our view core decompression, removal of the necrotic tissue and packing of the cancellous grafts into the core track are vital parts of the procedure.
Avascular necrosis of the femoral head commonly affects patients in the second, third and fourth decades of life. Prosthetic replacement of the hip in this group is complicated by the relatively long expected life span of the patient and finite life expectancy of the prosthesis. [1] [2] [3] The optimal treatment requires preservation of the femoral head or at least to delay its collapse or the onset of degenerative changes. Avascular necrosis accounts for between 5% and 12% of total hip replacements. 4 Many conditions, both traumatic or atraumatic, have been associated with avascular necrosis. 5 The natural history of the condition is one of progression, with subchondral fractures leading to collapse and osteoarthritis. [6] [7] [8] Mont and Hungerford 4 in a meta-analysis describing the natural history, found that the femoral head was preserved in between 13% and 35% of hips depending upon the stage of the disease.
The non-prosthetic treatment of avascular necrosis is still controversial. Many options have been described, including core decompression, vascularised and non-vascularised bone grafting and various osteotomies. 7 The use of a non-vascularised graft is more appealing than that of a vascularised graft because it is less technically demanding and may reduce donor-site morbidity. Non-vascularised autologous bone grafting has numerous other theoretical advantages. The procedure provides decompression of the avascular lesion and removal of the necrotic bone in order to interrupt the cycle of ischaemia and interosseous hypertension. Grafting of the defect with fresh cancellous bone and placement of a cortical strut support the subchondral surface and introduce a scaffold for repair and remodelling of subchondral bone. It is a relatively simple procedure which can be performed by one surgeon.
Our study describes the long-term results of core decompression, popularised by Phemister, 9 Boettcher, Bonfiglio and Smith 10 and Bonfiglio and Bardenstein, 11 combined with placement of an autologous cortical tibial graft or a fibular allograft. The latter technique was introduced in order to reduce donor-site morbidity from the tibial graft before we analysed the different patients.
Patients and Methods
Between 1984 and 2000, we treated 80 hips in 65 patients with avascular necrosis using a cortical strut graft after core decompression. The diagnosis was based on radiological analysis and clinical history. From 1984 we used antero-posterior and lateral radiographs and technetium-99 bone scans; after 1990, MRI was used to evaluate the extent and degree of avascular necrosis. In all cases the final diagnosis was determined by histological examination on intra-operative biopsy. Of the 80 cortical strut grafts, the first 18 were tibial autografts (1984 to 1990) and, thereafter, 62 fibular allografts were used. The patients in both groups were similar in all characteristics (Table I) . A total of 56 hips in 44 men and 24 hips in 21 women underwent surgery. Bilateral operations were performed on 12 men and three women. The mean age at the time of surgery was 36 years ( SD 13.2) .
Clinical conditions associated with avascular necrosis included steroid use (48 hips), trauma (15) , alcohol abuse (7), anabolic steroid use (1), radiotherapy (1) and idiopathic disorders (8) . Of the 65 patients, nine suffered from systemic lupus erythematosus, nine had undergone an organ transplant and two had sarcoidosis. The 15 patients who underwent bilateral treatment suffered from avascular necrosis because of steroid use.
All patients had a minimum follow-up of three years. The mean follow-up was seven years ( SD 4.8). All but two patients were available for follow-up. Of the two who were not available one died four years after surgery and one could not be traced. Both patients had been treated by an autogenous tibial strut graft. Radiological evaluation. The most widely used classification systems were introduced by Ficat, 12 Steinberg, Hayken and Steinberg, 13 and Gardeniers. 14 The last two also used MRI, which was not available for all our patients. Consequently, we used the Ficat-Arlet classification (Table II) III and ten as stage IV. The combined necrotic angle measurement of Kerboul et al 15 was used to determine the extent of the avascular area on the pre-operative radiographs. This measurement evaluates the extent of the necrosis by measuring the arc of involvement of the hip on the anteroposterior and lateral radiographs. At follow-up the Ficat-Arlet stage and the position of the autologous graft or the allograft were judged with respect to the distance between the lesion and the subchondral bone. All measurements were made by one of the authors (SBK). Clinical evaluation. We used the two parts of the scale of Merle d'Aubigné and Postel 16 and Merle d'Aubigné et al 17 as modified by Charnley, 18 for clinical evaluation pre-operatively, one year post-operatively and at the latest followup (Table III) . Operative technique. The patient is placed in a supine position on a fracture table without traction. A straight lateral approach is used in combination with an image intensifier in order to locate the avascular lesion. After placing a guide-wire in the necrotic area, which is located pre-operatively by MRI or radiographs, an 8 mm hole is drilled through the base of the greater trochanter, along the femoral neck and into the necrotic area of the head (Fig. 1 ). A core biopsy is then taken for histological examination. Curettes are used under fluoroscopic control to remove necrotic bone from the anterosuperior aspect of the femoral head and autogenous cancellous bone is impacted into the excavated area. When a tibial autograft is used, cancellous bone is harvested from the proximal tibia and with a fibular allograft the cancellous bone is harvested from the greater trochanter. After these procedures the tibial or fibular graft is inserted into the core and its position is checked by image intensifier.
The position of the graft is considered to be best when its proximal end is within the necrotic lesion and no more than 10 mm beneath the subchondral bone, as advised by Smith, Bonfiglio and Montgomery. 19 Post-operatively patients are non-weight-bearing with crutches for six weeks.
All procedures were performed according to this specific protocol by four different surgeons or residents supervised by them. Statistical analysis. For statistical evaluation the statistical program SPSS 11.0.1 (SPSS Inc, Chicago, Illinois) was used. A paired Student t -test was used to analyse differences between groups. The level of significance was set at p < 0.05. Univariate and multivariate Cox regression were used to study the influence of various clinical and demographic parameters on the time to failure. A Kaplan-Meier survival analysis, with a log-rank significance test for group differences, was also performed. The Spearman's rank correlation coefficient was used to study the correlation between various clinical and demographic parameters. The end-point was clinical failure of the structural bone grafting, defined as the need for an operation, or a poor Merle d'Aubigné and Postel score (< 8 points). 16 Clinical success was defined as a good or excellent score (> 9 points) and no revision surgery (Table III, functional grade) . A second endpoint was radiological failure, as defined by a progression in the Ficat-Arlet staging during follow-up compared with pre-operatively. A radiological success was defined as no radiological progression.
Results
Of the 78 treated hips available for evaluation 34 (44%) were revised at a mean of four years ( SD 3.8, 1 to 15). Revision consisted of total hip arthroplasty in 26 hips, Thomine-cup resurfacing arthroplasty (Protek GmbH, Switzerland) in seven and arthrodesis in one. Eight (10%) patients reached their end-point because of a poor Merle d'Aubigné Postel score (< 8) after a mean period of 6.5 years (5 to 13). Consequently, 42 patients (54%) had clinical failure (secondary surgery or a poor Merle d'Aubigné and Postel score (< 8 points) at a mean of 4.5 years (1 to 15).
There were complications in seven patients (9%). In the group with a fibular graft two had a fracture through the femoral drill hole, and in three perforation of the subchondral plate occurred during surgery. Two complications occurred in the group receiving a tibial graft; one patient had a tibial fracture at the donor site and one a lesion of the peroneal nerve. There was no significant difference in the complication rates for the two types of graft. Postel score for the 44 non-revised hips was 9.2 ( SD 2.22), which was a significant improvement (p < 0.001) compared with the pre-operative score. Of the non-revised hips 24 (55%) had a good or very good functional score at their latest follow-up. There was no significant difference (p = 0.238) between the improvement in the Merle d'Aubigné and Postel score for the two operative groups (tibial autograft and fibular allograft).
The clinical success rate (no revision and Merle d'Aubigné and Postel score > 9 points) at a mean follow-up of nine years (4 to 17) for Ficat-Arlet stage 0 was 66%, for stage I it was 0%, for stage IIA 32%, for stage IIB 25%, for stage III 31% and for stage IV 22% (Table IV) .
Pre-operatively, there had been a significant negative correlation (Spearman rank correlation coefficient -0. Univariate Cox regression analysis showed a significantly higher (p = 0.026) chance of clinical failure in women than in men (hazard ratio 2.04, 95% confidence interval (CI) 1.09 to 3.81). Patients older than 30 years had a significantly higher (p = 0.004) chance of clinical failure compared with those younger than 30 years of age (multivariate Cox regression hazard ratio 2.83; 95% CI 1.32 to 6.05) with correction for gender. Radiological evaluation. There was a significant correlation (Spearman rank correlation 0.3; p = 0.006) between the pre-operative Ficat-Arlet stage and the need for revision, but no correlation between the Kerboul combined necrotic angle measurement and revision. There was also no correlation between the distance of the graft to the subchondral bone and revision. The paired t -test showed a significant difference between the mean Ficat-Arlet stage of 2.6 ( SD 0.97) measured pre-operatively and that post-operatively 3.7 ( SD 0.77) (p = 0.001). After one year 24 patients (31%) had an increased Ficat-Arlet stage. At the latest follow-up 25 (57%) of the 44 non-revised hips had an increased FicatArlet stage.
The radiological success rate (no progression in FicatArlet staging) at a mean follow-up of nine years (4 to 17) for Ficat-Arlet stage 0 was 17.0%, for stage I 0%, for stage IIA 24%, for stage IIB 25% and for stage III 26%. The hips which showed a progression in their Ficat-Arlet stage did not have a higher chance of subsequent clinical failure (Table V) . Survivorship. A Kaplan-Meier survivorship analysis was performed with a clinical end-point (subsequent operation or a Merle d'Aubigné and Postel score < 8 points), a radiological end-point (a progression in the Ficat-Arlet staging) or revision (total hip arthroplasty, Thomine-cup resurfacing arthroplasty and arthrodesis) as an end-point.
Survivorship analysis with the clinical end-point showed a mean survival of 59% at five years (95% CI 48 to 70) and a mean of 44% at ten years (95% CI 31 to 56). There was a difference in survival between the two operative techniques, although this was not significant (p = 0.114). Treatment by a tibial autograft showed a mean survival rate of 75% at six years (95% CI 54 to 96) and a mean of 63% at ten years (95% CI 39 to 86). After 14 years, 56% of the hips treated by a tibial autograft needed revision. Survivorship analysis of the fibular allograft showed a mean survival rate of 49% at six years (95% CI 36 to 62) and a mean of 38% at ten years (95% CI 24 to 75) (Fig. 2) . Kaplan-Meier survivorship analysis with a clinical and radiological end-point showed a mean survival rate of 55% at five years (95% CI 44 to 66) and a mean of 33% at ten years (95% CI 21 to 44). When a combination of the clinical and radiological end-points was used there was a significant difference (p = 0.002) between the two operative techniques. The tibial autograft showed a mean survival rate of 75% at six years (95% CI 54 to 96) and a mean of 63% at ten years (95% CI 39 to 86). However, the fibular allograft showed a mean survival rate of 42% at six years (95% CI 30 to 55) (Fig. 3) .
Survivorship analysis with revision surgery for any reason as an end-point showed a mean survival rate of 66% (95% CI 55 to 77) at five years and of 52% (95% CI 39 to 65) at ten years (Fig. 4) . The survivorship analysis of the hip for the different Ficat-Arlet stages showed a mean survival rate of 83% (95% CI 68 to 98) for stage 0, 0% for stage I, 80% (95% CI 66 to 94) for stage IIA, 63% (95% CI 39 to 87) for stage IIB, 54% (95% CI 27 to 81) for stage III and 56% (95% CI 23 to 86) for stage IV at five years.
Confounding factors considered as risk factors for avascular necrosis (e.g. alcohol intake, smoking), the pre-operative Merle d'Aubigné scores and the pre-operative Ficat classification were not related to post-operative collapse of the femoral head and, consequently, were not related to the mean survivorship.
Discussion
Our clinical findings differ little from those which have been previously reported and our clinical data show acceptable results over a follow-up of nine years, although some discrepancy still remains between various published reports. 20 It is difficult to compare different studies in the literature because of the high variability in patient populations (e.g. stage of avascular necrosis, age, operative technique, etc). We did not exclude the bilaterally-treated patients as we did not believe this led to a bias in treatment since the end-point was revision surgery and a poor clinical outcome. The radiological findings were generally less favourable and in contrast with the findings of Buckley, Gearen and Petty 21 we found a significant difference (p = 0.002) in survivorship (clinical and radiological end-point) between treatments by tibial autograft and that by a fibular allograft.
Our treatment was only symptomatic and was not intended to revascularise the bone. Finite-element analyses have shown that, ideally, the graft should be placed as close as possible to the subchondral bone, and in a lateral position. 19, [21] [22] [23] In our study there was no significant correlation between survival of the hip and the distance of the graft to the subchondral bone.
In earlier studies non-vascularised bone-grafting procedures had encouraging clinical results. 10, 21, 24, 25 At a mean of eight years (two to 19), Buckley et al 21 reported excellent results in 18 (90%) of 20 hips in which a Ficat and Arlet stage-I or stage-II lesion had been treated by core decompression combined with tibial autografting and fibular grafting (both autogenous and allogenic). Boettcher et al 10 initially reported success in 27 (71%) of 38 hips six years after the use of cortical tibial strut grafts. However, in a long-term study by Smith et al, 19 which included the original 38 patients evaluated by Boettcher et al, 10 40 (71%) of 56 hips had a poor clinical result after a mean follow-up of 14 years (4 to 27). Later studies showed a high rate of radiological progression even in hips with a pre-collapse stage of avascular necrosis. Nelson and Clark 26 evaluated the results of 52 hips treated by Phemister bone grafting and concluded that the technique was not effective in arresting progression and that its role in the treatment of avascular necrosis was uncertain. Dunn and Grow 27 reported only four good results in 23 patients treated in this way.
In a comprehensive review of the literature, Mont and Hungerford 4 reviewed 24 studies involving 1206 hips which had been treated only by core decompression. They included studies in which small cancellous grafts had been packed at the apex of the core track (220 hips). Stratification of the hips which had undergone core decompression according to the stage of avascular necrosis, gave better results for the early stages. The mean rate of survival, judged by clinical success, was 84% for Ficat-Arlet stage I, 65% for stage II and 47% for stage III after a mean followup of 2.5 years. After this, 33% of the hips required further operation.
Currently, three distinct approaches can be used to insert a cortical strut graft into the femoral head: 1) a core track; 2) a window in the femoral neck (a 'light-bulb' procedure); or 3) a trapdoor made through the articular cartilage in the femoral head. For the past 15 years we have used the strutgrafting procedure through a core track, as first described by Phemister, 9 since it is a relatively simple, extra-articular, reproducible procedure.
When we first undertook this technique we used a tibial autograft, as originally described by Phemister. 9 However, of our 16 tibial autografts, two had donor-site complications. In order to reduce this risk we then used a fibular allograft.
Several groups of surgeons have performed free vascularised fibular grafting procedures in large series of patients, with high rates of satisfactory results. [28] [29] [30] However, the complexity of the procedure, its complication rate and the length of the operation have raised questions regarding its efficacy. In a series of 103 hips Urbaniak et al 30 reported that 30% required a subsequent operation at a median of seven years compared with 43% in our series. Survivorship analysis in their series showed a conversion rate to a total hip arthroplasty within five years of 89% for stage IIA (our study 80%), 77% for stage IIB (our study 63%), 71% for stage III (our study 54%) and 73% for stage IV (our study 56%). In a more recent study by Marciniak, Furey and Shaffer, 31 58% of hips required a subsequent operation after eight years. It appears that patients treated by vascularised fibular grafting have a higher complication rate. Vail and Urbaniak 32 found in their study of 247 vascularised fibular grafts, a donor-site morbidity of 35%. Obviously, an advantage of a fibular allograft is an absence of this.
There is no consensus regarding the indication for nonvascularised bone grafting. Proponents recommend it for hips with depression of the femoral head of less than 2 mm. Some investigators have reported good results in patients with a collapsed femoral head, but only small numbers of patients have been studied.
Recent advances in our understanding of the pathophysiology of avascular necrosis suggest that a decrease in the mesenchymal stem-cell pool of the proximal femur may provide insufficient osteoblasts to meet the needs of bone remodelling in the early stages of the disease. 33 This insufficiency may explain the inadequate repair mechanism, which may then lead to collapse of the femoral head.
In our view core decompression, removal of the necrotic tissue and packing of the cancellous grafts into the core track are the most important parts of the procedure. The strut graft has a minimal effect on the outcome of the procedure since we found no correlation between the relationship of the graft to the subchondral bone and the subsequent revision rate. This hypothesis is also supported by the good results of the 'light-bulb' and bone impaction grafting techniques. [34] [35] [36] [37] The effectiveness of these procedures may be related to the availability of stem cells endowed with osteogenic properties, arising from an increase in the supply of such cells to the femoral head through bone-marrow implantation. 38, 39 Our hypothesis for the difference in survival between the two grafts, despite the fact that in both types cancellous autograft is used, is that the autogenous cancellous bone of the proximal tibia is not only of better quality, but also that a larger volume can also be harvested in comparison with the trochanteric region. Furthermore, the large autologous tibial graft itself has osteogenic properties while allograft only has osteoconductive properties.
This hypothesis is supported by the two studies by Hernigou et al 33 and Hernigou and Beaujean. 40 They demonstrated decreased activity of bone-marrow cells in the intertrochanteric region and iliac crest in patients with AVN related to steroid therapy or alcohol abuse. This could explain the difference which we found between tibial autogenous graft and fibular allograft with autologous trochanteric cancellous graft.
In summary, our study demonstrates that the Phemister technique for the treatment of avascular necrosis is a relatively simple, extra-articular and reproducible procedure. In our view, core decompression, removal of the necrotic tissue and packing of the cancellous grafts into the core track are vital parts of the procedure. However, further studies are necessary to determine the best cancellous donor site.
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